Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CHRONICLE Study: A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals With Severe Asthma in the United States

NCT03373045 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT03373045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03373045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CHRONICLE Study: A Longitudinal Prospective Observational Study of the Characteristics, Treatment Patterns and Health Outcomes of Individuals With Severe Asthma in the United States
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 27, 2018
Completion date
February 14, 2025
Enrollment
18 (actual)
Sites
175

Conditions

As the registry lists them; a condition with its own page is linked.

asthma